Search results
Results from the WOW.Com Content Network
A 2016 review in The New England Journal of Medicine said that although there was a lot of hype and anecdotes surrounding medical cannabis and epilepsy, "current data from studies in humans are extremely limited, and no conclusions can be drawn". [32] The mechanisms by which cannabis may be effective in the treatment of epilepsy remain unclear ...
The CNN documentaries received widespread publicity and popularized Charlotte's Web as a possible treatment for epilepsy and other conditions. [14] Colorado has legalized both the medicinal and recreational use of marijuana, and many parents have flocked there with their suffering children in search of Charlotte's Web and other forms of medical ...
Figi began taking oil from the marijuana strain, "Hippie's Disappointment," which contained low THC, [3] and was later renamed Charlotte's Web. [4] With the use of Charlotte's Web, Figi experienced an immediate reduction in her epileptic seizures, down from 300 a week to two or three per month. [ 5 ]
“The Refractory Epilepsy Specialist Clinical Advisory Service (RESCAS) was set up in 2020 to support paediatric neurologists when considering medical cannabis (and other new treatments) in cases ...
Medical cannabis, medicinal cannabis or medical marijuana (MMJ) refers to cannabis products and cannabinoid molecules that are prescribed by physicians for their patients.
Medically, it is an anticonvulsant used to treat multiple forms of epilepsy. [4] It was discovered in 1940 and, as of 2024 clinical research on CBD included studies related to the treatment of anxiety, addiction, psychosis, movement disorders, and pain, but there is insufficient high-quality evidence that CBD is effective for these conditions.
Proposition 215 – the Compassionate Use Act of 1996 – was subsequently approved with 56% of the vote, legalizing the use, possession, and cultivation of cannabis by patients with a physician's recommendation, for treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraine, or "any other illness for which ...
In 2015, GW Pharmaceutical initiated Phase 3 clinical trials of cannabidiol oral solution for treatment of two rare disease in children – Dravet syndrome and Lennox–Gastaut syndrome. [17] In August 2015, GW received FDA Fast Track Development Program designation from the US Food and Drug Administration for use of the drug candidate to treat ...